Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Pyridine Acetonitrile. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115286615A details a mild, high-yield synthesis of racemic nicotine avoiding cryogenic conditions, offering significant cost reduction and supply chain stability for electronic cigarette and pharmaceutical manufacturers.
Patent CN115286615A details a mild, high-yield synthetic route for racemic nicotine using 3-pyridine acetonitrile, offering significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Patent CN113999201A details a novel asymmetric synthesis of S-nicotine, offering high purity and cost efficiency for pharmaceutical intermediate manufacturing.